Browse Technologies
Browse Technologies
Technology Keyword Search
Microbiome
Search Results
Displaying: 1 - 7 of 7 Results
Isolating live cells after high-throughput, long-term, time-lapse microscopy
Researchers led by Johan Paulsson have engineered a high-throughput microfluidic device for multigenerational culturing, imaging, and tracking of single-cell lineages. The platform is highly customizable and is compatible with many cell types,…
DBD
- Irit Ben-Chelouche
Investigators
- Johan Paulsson
Diamond tip for NV (nitrogen vacancy) magnetometry
The ability to map magnetic field distributions with high sensitivity and nanoscale resolution is of crucial importance for fundamental studies ranging from material science to biology, as well as for the development of new applications in…
Investigators
- Amir Yacoby
- Xu Zhou
- Rainer Stohr
- Ling Xie
Photostick: Physical isolation of single cells from tissue, for further propagation and single cell sequencing and omics
Photostick enables the physical selection of single cells from large populations in diverse environments. The novel process entails photochemical immobilization of live cells with patterned illumination, followed by removal of unwanted cells with…
DBD
- Yelena Bisharyan
Investigators
- Adam Cohen
- Miao-Ping Chien
Microbiome reagents to treat inflammatory bowel disease and restore gut homeostasis
Reactive oxygen species (ROS) and oxidative stress are believed to cause and/or aggravate several diseases, including inflammatory diseases like inflammatory bowel disease (IBD). Antioxidants have the ability to neutralize the damaging effects of…
DBD
- Grant Zimmermann
Investigators
- Wendy Garrett
Innovative microbiome anti-oxidants to repair UV damaged skin and slow aging
Ultraviolet (UV) radiation from the sun drives accumulation of reactive oxygen species (ROS) and inflammation in the skin. UV radiation also depletes skin cells of antioxidant enzymes, including superoxide dismutase (SOD). Increased ROS and…
DBD
- Grant Zimmermann
Investigators
- Wendy Garrett
Inhibiting Microbial Metabolism of Levodopa to Increase Availability in the CNS
Parkinson’s disease (PD) impacts 10 million people globally, with 60,000 Americans newly diagnosed every year. Levodopa remains the gold standard treatment for PD, despite limitations including side effects and peripheral metabolism. Current…
DBD
- Yelena Bisharyan
Investigators
- Emily Balskus
Control of host homeostatic immunity by a microbiome-derived immunomodulatory lipid
Akkermansia muciniphila, a species of the human gut microbiome, has been robustly associated with positive systemic effects on host metabolism and obesity, favorable response to checkpoint blockade in cancer immunotherapy, and maintenance of…
DBD
- Grant Zimmermann
Investigators
- Jon Clardy